Trifluoroacetic acid → (RS)-5,6-difluoro-1-methyl-2-piperidin-2-ylmethyl-1H-benzoimidazole
反応式
C(OC([N:8]1[CH2:13][CH2:12][CH2:11][CH2:10][CH:9]1[CH2:14][C:15]1[N:19]([CH3:20])[C:18]2[CH:21]=[C:22]([F:26])[C:23]([F:25])=[CH:24][C:17]=2[N:16]=1)=O)(C)(C)C.FC(F)(F)C(O)=O>>[F:25][C:23]1[C:22]([F:26])=[CH:21][C:18]2[N:19]([CH3:20])[C:15]([CH2:14][CH:9]3[CH2:10][CH2:11][CH2:12][CH2:13][NH:8]3)=[N:16][C:17]=2[CH:24]=1参加物
3
実験手順
(RS)-2-(5,6-Difluoro-1-methyl-1H-benzoimidazol-2-ylmethyl)-piperidine-1-carboxylic acid tert-butyl ester, D60 (0.5 g) was treated with trifluoroacetic acid (5 ml) as described for Description 6 to afford the title compound (0.363 g)
出典と根拠
- ORDレコード
- ord-b02f8042ea544e779ded9dc36fc151f7
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07928124B2
反応ノート
読み込み中…